# JPM — local-model

## Metadata

ticker: JPM
arm: local-model
judge_prompt_version: v2
context_sha256: 0e1cd5e9168b8ce483eafc129f76af55aa309532f2ef6c53e9232d432f05d4ef
local_model_served_name: qwen2.5-7b-instruct
local_model_dir: qwen2.5-7b-instruct
local_model_backend: openai
local_model_url: http://vllm.financial-agent.svc:8000
local_model_sampling: {"max_tokens": 512, "min_p": 0.0, "repetition_penalty": 1.1, "temperature": 0.1, "top_k": 20, "top_p": 0.8}

## Retrieved source context

STOCK DATA:
{
  "ticker": "JPM",
  "company_name": "JPMorgan Chase & Co.",
  "current_price": 337.53,
  "currency": "USD",
  "market_cap": 897217593344.0,
  "pe_ratio": 14.473843,
  "forward_pe": 13.507689,
  "week_52_high": 366.5,
  "week_52_low": 279.1,
  "revenue": 186328006656.0,
  "net_income": 63634001920.0,
  "profit_margin": 0.34921002,
  "dividend_yield": 1.94,
  "sector": "Financial Services",
  "industry": "Banks - Diversified"
}

NEWS ARTICLES:
[]

SEC FILING SUMMARIES:
{
  "10-K": {
    "form_type": "10-K",
    "filing_date": "2026-02-13",
    "summary": "Item 1A. Risk Factors. The following discussion sets forth the material risk factors that could affect JPMorganChase\u2019s financial condition and operations. Readers should not consider any descriptions of these factors to be a complete set of all potential risks that could affect the Firm. Any of the risk factors discussed below could by itself, or combined with other factors, materially and adversely affect JPMorganChase\u2019s business, results of operations, financial condition, capital position, liquidity, competitive position or reputation, including by materially increasing expenses or decreasing revenues, which could result in material losses or a decrease in earnings. Summary The principal risk factors include: \u2022 Legal and Regulatory risks, including the impact of extensive supervision an"
  },
  "10-Q": {
    "form_type": "10-Q",
    "filing_date": "2026-08-06",
    "summary": "Item 1A: Risk Factors on pages 9\u201331 of JPMorganChase\u2019s 2025 Form 10-K for information on the financial consequences to holders of the Firm\u2019s debt and equity securities in a resolution scenario. Refer to Other capital requirements on page 98 of JPMorganChase\u2019s 2025 Form 10-K for additional information on TLAC. 50 U.S. broker-dealer regulatory capital J.P. Morgan Securities JPMorganChase\u2019s principal U.S. broker-dealer subsidiary is J.P. Morgan Securities. J.P. Morgan Securities is subject to the regulatory capital requirements of Rule 15c3-1 under the Securities Exchange Act of 1934 (the \u201cNet Capital Rule\u201d). J.P. Morgan Securities is also registered as a futures commission merchant and is subject to regulatory capital requirements, including those imposed by the SEC, the Commodity Futures Tr"
  }
}

RAG — SEC HIGHLIGHTS:
[From Pinecone cache] I cannot provide a summary of the latest 10-K and 10-Q based on the information provided. The context materials only contain excerpts from JPMorgan Chase's risk factors disclosure, specifically focusing on legal, regulatory, and operational risks the company faces.

To provide a comprehensive summary of the latest 10-K and 10-Q filings, I would need access to the complete documents, including sections covering:

- Financial performance and results of operations
- Balance sheet and liquidity analysis
- Capital adequacy and management
- Business segment performance
- Management's discussion and analysis (MD&A)
- Cash flow statements
- Significant accounting policies and changes
- Forward-looking guidance

The excerpts available only address risk factors related to regulatory oversight, legal proceedings, competitive disadvantages from differential regulation, and operational compliance costs. While these are important considerations, they represent only a portion of what would be included in a full 10-K or 10-Q summary.

If you have access to the complete filings or specific sections you'd like me to analyze, I'd be happy to help summarize those materials.

RAG — RISK FACTORS:
[From Pinecone cache] # Primary Risk Factors Disclosed

JPMorgan Chase discloses the following principal risk factors:

1. **Legal and Regulatory Risks** – Extensive supervision and regulation, changes in law interpretation or enforcement, differences in regulatory implementation across jurisdictions, governmental policies affecting certain industries, penalties from litigation or investigations, and potential losses to security holders if the firm enters resolution.

2. **Political Risks** – Negative effects on businesses due to economic uncertainty from political developments.

3. **Market Risks** – Unfavorable economic and market events, political developments, changes in interest rates and credit spreads, and market fluctuations affecting businesses, investments, and earnings.

4. **Credit Risks** – Adverse changes in financial condition of clients and counterparties, declines in collateral value, and concentrations of credit risk.

5. **Liquidity Risks** – Constrained liquidity impairing operations, dependence on subsidiaries for funding, and adverse effects from credit rating downgrades.

6. **Capital Risks** – Limitations on capital distribution to shareholders if regulatory capital requirements are not satisfied.

7. **Operational Risks** – Dependence on operational systems and employees, cyber attacks, risks from new products or technologies, data management issues, vendor oversight, and risks related to the risk management framework and financial reporting controls.

8. **Strategic Risks** – Ineffective business strategies, significant competition, and impacts from climate change.

9. **Conduct Risks** – Negative impacts from employee misconduct.

10. **Reputation Risks** – Negative commercial impacts from client decisions, conflicts of interest, and failure to meet fiduciary obligations.

11. **Country Risks** – Impacts from hostilities between countries and local economic, political, regulatory, and social factors.

12. **People Risks** – Criticality of attracting and retaining qualified employees.

## Pre-written sections (judge input)

### Financial Health

JPMorgan Chase & Co. (JPM) currently trades at $337.53 per share, with a market capitalization of approximately $897.22 billion. The company has a Price-to-Earnings (P/E) ratio of 14.47 and a forward P/E ratio of 13.51, indicating a relatively stable valuation. Revenue stands at $186.33 billion, and the net income is $63.63 billion, reflecting a robust profit margin of 34.92%. These metrics suggest strong financial health and stability within the sector.

### Recent Developments

JPMorgan Chase filed its 2025 Form 10-K in February 2026, highlighting extensive legal and regulatory risk factors as key concerns for the firm's operations and financial performance. The most recent 10-Q filing from August 2026 emphasizes ongoing capital requirements and regulatory compliance obligations, particularly regarding TLAC (Total Loss-Absorbing Capacity) and broker-dealer capital standards. These regulatory filings underscore the persistent compliance burden facing large financial institutions, which could impact future profitability through increased operational expenses. For investors, JPM's strong fundamentals—including a 34.9% profit margin, 14.5x P/E ratio, and 1.94% dividend yield—suggest the bank is managing these regulatory pressures effectively, though continued monitoring of regulatory changes remains important.

### SEC Filing Highlights

I cannot provide accurate SEC filing highlights without access to JPMorgan Chase's complete 10-K or 10-Q documents. The available data contains only risk factor disclosures and does not include critical sections such as financial performance, balance sheet analysis, segment results, or management's discussion and analysis. To deliver a reliable investment brief section, I would need access to the full filing materials covering earnings, capital metrics, and operational results. Please provide the complete 10-K or 10-Q documents for a comprehensive summary.

### Risk Factors

- **Legal and Regulatory Risks** – Subject to extensive supervision and regulation, facing potential penalties from litigation or investigations, and risks associated with changes in laws and regulations.
- **Market Risks** – Vulnerability to market fluctuations, changes in interest rates, and credit spread variations that can impact earnings and investments.

## Audited (Exec Summary + Outlook)

### Executive Summary
JPMorgan Chase & Co. is one of the world's largest financial institutions, operating across banking, investment management, and financial services, with revenue of $186.33 billion, net income of $63.63 billion, and a market capitalization of approximately $897.22 billion. The stock is notable now for its combination of a relatively modest valuation — reflected in a P/E ratio of 14.47 and a forward P/E of 13.51 — alongside a 34.92% profit margin and a 1.94% dividend yield, suggesting the market is pricing in meaningful regulatory and macro uncertainty despite the firm's demonstrated earnings power. The single most important near-term variable shaping the investment outcome is the trajectory of regulatory capital requirements, particularly around TLAC and broker-dealer capital standards, which will directly influence how much of JPM's earnings capacity can be returned to shareholders or deployed for growth.

### Outlook
The directional outlook for JPMorgan Chase is **cautiously constructive**, supported by the firm's demonstrated ability to generate strong profitability — as evidenced by its 34.92% net margin — even amid a demanding regulatory environment. The primary tailwind is JPM's scale and diversification, which historically allows it to absorb compliance costs and interest rate volatility better than smaller peers. The key headwinds to monitor are the evolution of TLAC and broker-dealer capital standards, which could constrain capital flexibility, and broader market risks including interest rate movements and credit spread widening, both of which are explicitly flagged in the firm's own risk disclosures. Investors should watch the pace and direction of regulatory rulemaking, the interest rate environment and its effect on net interest income, and any material developments in the firm's ongoing legal and litigation exposure. What would strengthen the thesis: a more favorable regulatory posture that reduces compliance burden and frees capital for shareholder returns. What would weaken it: an escalation of legal or regulatory penalties, a sharp deterioration in credit quality, or a sustained adverse shift in interest rates that compresses margins.

---
*This brief is for informational purposes only and does not constitute financial advice.*

## Judge findings

I will now systematically audit every specific quantitative figure, price target, threshold, ratio, metric, percentage, named product milestone, or forward-looking number in the Executive Summary and Outlook sections.

---

**EXECUTIVE SUMMARY**

---

CLAIM: "revenue of $186.33 billion"
LABEL: SUPPORTED
REASON: The raw source data lists revenue as $186,328,006,656, which rounds to $186.33 billion, and the same figure appears in the Financial Health pre-written section.

---

CLAIM: "net income of $63.63 billion"
LABEL: SUPPORTED
REASON: The raw source data lists net_income as $63,634,001,920, which rounds to $63.63 billion, consistent with the Financial Health pre-written section.

---

CLAIM: "market capitalization of approximately $897.22 billion"
LABEL: SUPPORTED
REASON: The raw source data lists market_cap as $897,217,593,344, which rounds to approximately $897.22 billion, consistent with the Financial Health pre-written section.

---

CLAIM: "P/E ratio of 14.47"
LABEL: SUPPORTED
REASON: The raw source data lists pe_ratio as 14.473843, which rounds to 14.47, consistent with the Financial Health pre-written section.

---

CLAIM: "forward P/E of 13.51"
LABEL: SUPPORTED
REASON: The raw source data lists forward_pe as 13.507689, which rounds to 13.51, consistent with the Financial Health pre-written section.

---

CLAIM: "34.92% profit margin"
LABEL: SUPPORTED
REASON: The raw source data lists profit_margin as 0.34921002, which equals 34.921%, rounding to 34.92%, consistent with the Financial Health pre-written section.

---

CLAIM: "1.94% dividend yield"
LABEL: SUPPORTED
REASON: The raw source data explicitly lists dividend_yield as 1.94, consistent with the Recent Developments pre-written section.

---

CLAIM: "regulatory capital requirements, particularly around TLAC and broker-dealer capital standards"
LABEL: SUPPORTED
REASON: The 10-Q filing summary explicitly references TLAC (Total Loss-Absorbing Capacity) and broker-dealer capital standards (J.P. Morgan Securities, Rule 15c3-1), and the Recent Developments pre-written section restates these same items.

---

**OUTLOOK**

---

CLAIM: "34.92% net margin"
LABEL: SUPPORTED
REASON: The raw source data lists profit_margin as 0.34921002 (34.921%), which rounds to 34.92%, consistent with all pre-written sections.

---

CLAIM: "evolution of TLAC and broker-dealer capital standards, which could constrain capital flexibility"
LABEL: SUPPORTED
REASON: TLAC and broker-dealer capital standards are explicitly named in the 10-Q filing summary and restated in the Recent Developments pre-written section; the characterization of constraining capital flexibility is a direct restatement of the Capital Risks factor ("Limitations on capital distribution to shareholders if regulatory capital requirements are not satisfied").

---

CLAIM: "interest rate movements and credit spread widening, both of which are explicitly flagged in the firm's own risk disclosures"
LABEL: SUPPORTED
REASON: The Risk Factors pre-written section and RAG Risk Factors explicitly list "changes in interest rates and credit spreads" and "Market Risks" as disclosed risk factors in JPM's filings.

---

CLAIM: "a sharp deterioration in credit quality"
LABEL: SUPPORTED
REASON: The RAG Risk Factors section explicitly lists Credit Risks including "adverse changes in financial condition of clients and counterparties" and "declines in collateral value," supporting this as a named risk in the firm's disclosures.

---

**No additional quantitative figures, price targets, thresholds, named product milestones, or forward-looking numbers appear in the Executive Summary or Outlook sections beyond those audited above.** All claims are either directly supported by the raw source data or by the pre-written sections that were themselves derived from that data. No claims were found to be UNSUPPORTED or INFERENCE.
